← Back to Search

Performance-Based Strategy for Substance Abuse Intervention (SAT2HIV-II Trial)

N/A
Waitlist Available
Led By Bryan R Garner, PhD
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at the end of month 12
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if staff are more likely to successfully provide a brief intervention for substance use if they are given a monetary bonus for meeting performance targets.

Who is the study for?
This trial is for adults over the age of 18 who have been diagnosed with HIV and are dealing with substance use disorders or substance abuse.
What is being tested?
The study tests two strategies to improve substance abuse treatment in HIV care. One includes facilitation, training, feedback, and consultation (FTFC), while the other adds pay-for-performance bonuses (FTFC+PFP).
What are the potential side effects?
Since this trial involves non-medical interventions like training and financial incentives rather than drugs or medical procedures, traditional side effects are not applicable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at the end of month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at the end of month 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Implementation consistency
Implementation quality
Secondary study objectives
Days using primary substance
Generalized Anxiety Disorder 7-item (GAD-7)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Training, Feedback, Consultation, Facilitation, and P4PExperimental Treatment1 Intervention
An enhanced version of the multilevel implementation strategy
Group II: Training, Feedback, Consultation, and FacilitationActive Control1 Intervention
A multilevel implementation strategy

Find a Location

Who is running the clinical trial?

RTI InternationalLead Sponsor
197 Previous Clinical Trials
939,699 Total Patients Enrolled
Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
655,283 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,486 Total Patients Enrolled
Alyssa ToroStudy DirectorRTI International
Bryan R Garner, PhDPrincipal InvestigatorOhio State University
1 Previous Clinical Trials
827 Total Patients Enrolled

Media Library

The facilitation, training, feedback, consultation, and pay-for-performance (FTFC+PFP) Strategy Clinical Trial Eligibility Overview. Trial Name: NCT04687917 — N/A
Addiction Research Study Groups: Training, Feedback, Consultation, and Facilitation, Training, Feedback, Consultation, Facilitation, and P4P
Addiction Clinical Trial 2023: The facilitation, training, feedback, consultation, and pay-for-performance (FTFC+PFP) Strategy Highlights & Side Effects. Trial Name: NCT04687917 — N/A
The facilitation, training, feedback, consultation, and pay-for-performance (FTFC+PFP) Strategy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04687917 — N/A
~91 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top